Vincent Stimper retweetledi
We’re looking forward to meeting 1:1 with Machine Learning Engineers, ML Research Engineers and ML Research Scientists at @ICLR next week.
Register in the comments to meet us in Rio!
English
Vincent Stimper
288 posts
Vincent Stimper
@VStimper
Senior Research Scientist @IsomorphicLabs | Previously: @Microsoft, @Amazon, @Cambridge_Uni, @MPI_IS
Lausanne, Switzerland Katılım Ocak 2019
435 Takip Edilen1.2K Takipçiler
Vincent Stimper retweetledi
We recently released a technical report highlighting how @IsomorphicLabs’ drug design engine is achieving a step change in how we model complex biological mechanisms, consistently outperforming industry benchmarks. Read our blog to discover how we’re bridging the gap between structure prediction and rational drug design.
You can find the link in the comments.
English
Vincent Stimper retweetledi
“What I’ve always dreamed about doing, and the first thing I wanted to apply AI to was human health... What could be a more important use of AI.”
@demishassabis sat down with @ajs for a new episode of @Fortune500: Titans and Disruptors of Industry to discuss his vision behind founding Isomorphic Labs, and how our interdisciplinary team is moving closer to solving all disease.
youtube.com/watch?v=BhfTQX…
YouTube
English
Vincent Stimper retweetledi
Brilliant to see @Nature highlighting the power of @IsomorphicLabs’ generalisable drug design engine. @ewencallaway explores how it achieves high precision in predicting how proteins interact with potential drugs and antibody structures, even in cases that sit far outside its training data.
Read the full piece here: nature.com/articles/d4158…
English
Vincent Stimper retweetledi
A new blog and technical report (bit.ly/4a6KL2G) from @IsomorphicLabs shows SOTA performance across hardest modelling tasks in drug discovery more than twice AF3 level on low similarity protein-ligand, antibody-antigen, and exceeding FEP+ accuracy on binding affinity
English
Vincent Stimper retweetledi
The drug design engine we’re building at @IsomorphicLabs is extending the SOTA further across key benchmarks, showing huge progress in accuracy and capabilities critical for in-silico drug discovery. Incredible work from @maxjaderberg and the entire team at Isomorphic Labs!
Isomorphic Labs@IsomorphicLabs
Today we share a technical report demonstrating how our drug design engine achieves a step-change in accuracy for predicting biomolecular structures, more than doubling the performance of AlphaFold 3 on key benchmarks and unlocking rational drug design even for examples it has never seen before. Head to the comments to read our blog.
English
@VStimper @IsomorphicLabs Vincent’s all about improving cycle times
1. Those of drug development
2. His own on a bicycle
English
Today, we at @IsomorphicLabs are sharing some glimpses of what we have built in the past years. I’m especially proud of our ability to predict binding affinities, to which I have contributed.
Isomorphic Labs@IsomorphicLabs
Today we share a technical report demonstrating how our drug design engine achieves a step-change in accuracy for predicting biomolecular structures, more than doubling the performance of AlphaFold 3 on key benchmarks and unlocking rational drug design even for examples it has never seen before. Head to the comments to read our blog.
English
Vincent Stimper retweetledi
So proud of the @IsomorphicLabs team and incredibly privileged to have played a part in building IsoDDE. Huge milestone! 🚀 Check out what we’ve been working on below.
Isomorphic Labs@IsomorphicLabs
Today we share a technical report demonstrating how our drug design engine achieves a step-change in accuracy for predicting biomolecular structures, more than doubling the performance of AlphaFold 3 on key benchmarks and unlocking rational drug design even for examples it has never seen before. Head to the comments to read our blog.
English
Vincent Stimper retweetledi
Among other things, IsoDDE’s binding affinity predictions exceed gold standard physics-based methods—an important step toward AI-driven rational drug design.
Grateful to have contributed to this work alongside the Iso team, and hugely excited for the future we’re building towards every day: in real drug programs, accelerating discovery, transforming medicine.
Isomorphic Labs@IsomorphicLabs
Today we share a technical report demonstrating how our drug design engine achieves a step-change in accuracy for predicting biomolecular structures, more than doubling the performance of AlphaFold 3 on key benchmarks and unlocking rational drug design even for examples it has never seen before. Head to the comments to read our blog.
English
Read our blog post here, which also has a link to the technical report:
x.com/IsomorphicLabs…
Isomorphic Labs@IsomorphicLabs
Read our blog to find out more bit.ly/4a6KL2G
English
Vincent Stimper retweetledi
If you are heading to the @appliedmldays Intelligence Summit next week, don’t miss James Kirkpatrick’s keynote exploring the architecture of Isomorphic Labs’ drug design engine that can perform tasks bridging the gap between structure prediction and developing new potential medicines.
Head to the comments to register.
English
Vincent Stimper retweetledi
We’re thrilled to be embarking on a new research partnership with Johnson & Johnson, joining forces to apply @IsomorphicLabs’ multi-modal drug design engine across both small molecules and biologics.
In this work we are going to be taking on some of the toughest challenges in drug design together, to unlock new ways to treat diseases that have been considered out of reach.
bit.ly/4b2WRL2 @JNJInnovation
English
Vincent Stimper retweetledi
@IsomorphicLabs today announced a cross-modality and multi-target research collaboration with @JNJInnovation. The partnership brings together Isomorphic’s AI-first approach to drug design with Johnson & Johnson’s expertise in drug discovery to design novel molecules that might otherwise remain undiscovered.
Head to the comments for the full announcement.
English
Vincent Stimper retweetledi
Come to our talk at @NeurIPS 2025! On Thursday, you can hear first-hand from @SergeiIakhnin, @ja_kirkpatrick, and @sbos, as they share why our mission to solve all disease makes @IsomorphicLabs a special place to work and the live roles we’re hiring for.
You can find us at the Google booth #1533.
See you in San Diego!
English
Vincent Stimper retweetledi
PhD opportunities at the Cambridge Machine Learning Group @CambridgeMLG. Application deadline 2 Dec, 2025. More info: mlg.eng.cam.ac.uk/phd_programme_…
English
Vincent Stimper retweetledi
Our incoming President, @maxjaderberg shares more about the progress we’ve made so far and his vision for the next chapter at @IsomorphicLabs.
Read more from Max here: bit.ly/43S8TTa
English
Vincent Stimper retweetledi
Congratulations to our new incoming company President, @MaxJaderberg, who will lead @IsomorphicLabs through the next phase of development. As a founding member, Max has designed Iso’s pioneering approach to AI and brings an entrepreneurial founder’s mentality and a deep belief in our mission.
Huge thanks to our current company President, Colin Murdoch, who has been a steward in Iso’s journey since it was just an idea. Through Colin’s effective and thoughtful leadership, he has successfully scaled the company through its breakout phase, Colin will remain invested and closely involved in Iso in an ongoing advisory capacity.
Read more on our website: bit.ly/4prFFTk
English
Vincent Stimper retweetledi
Curious about what it’s like to work at Isomorphic Labs’ Swiss location? In our latest blog post we're taking you inside IsoLabs' Lausanne office to learn about its history and meet some of the Isos based there.
Since opening in 2023, Lausanne has grown into a close-knit hub where data engineers, ML researchers, computational biologists and software engineers work together to solve complex problems every day.
Head to the comments to read the blog!
English
Vincent Stimper retweetledi
Our Head of Medicinal Drug Design, @_rebecca_paul, will provide an insight into our work applying our innovative AI drug design engine to drug discovery at the SCI New Approaches in Medicinal Chemistry symposium on 12 November at 16:00 GMT in London.
If you're attending, don't miss Rebecca's session! Head to the comments to find out more.
English